Montecito Bank & Trust reports big quarter due to PPP loans
Montecito Bank & Trust’s total net income grew more than 15 percent in the second quarter, buoyed by increases in total assets, loan growth and deposit growth, the bank announced Aug. 10. Many of the bank’s key measures grew by leaps and bounds between June 30, 2019 and June 30, 2020. Montecito Bank & Trust’s Read More →
Read More →
Refinancing boom hits Central Coast
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →The Trade Desk beats analyst estimates, shares top $500
Share of The Trade Desk soared past $500 in after-hours trading on Aug. 6 after the company reported a significant earnings beat, as advertising spending started to resume in the second quarter. Year-over-year revenues declined for the first time for the Ventura-based advertising technology company, but at $139.3 million, they still beat average analyst estimates. Read More →
Read More →PennyMac’s quarter to remember
With mortgage rates at record lows and the homebuying and refinancing markets booming, PennyMac Financial Services, a Westlake Village mortgage lender, and its real estate investment trust both reported strong financial results on Aug. 6. PennyMac Financial Services announced a net income of $352.7 million for the second quarter of 2020, or $4.39 per share, Read More →
Read More →Union Bank unveils $10M grant program for underserved communities
Editor’s note: An earlier version of this article contained an error in the headline. Union Bank’s Community Recovery Program is grants, not loans. Union Bank is making it easier for marginalized communities to access much-needed grant funds through a new online portal. The Community Recovery Program is a portal through which the bank is pouring Read More →
Read More →Inogen revenue falls, but Q2 earnings beat analyst estimates
The COVID-19 pandemic continued to cut into Inogen’s revenue, as new physician referrals and patient mobility declined during a quarter usually marked by increased patient travel and demand. Revenue fell nearly 30 percent in the second quarter to $71.7 million, missing average analyst estimates, and net income of $2.7 million was down from $9.9 million Read More →
Read More →Amgen teams up with competitors in COVID treatment trial
Amgen has joined two of its competitors in launching a trial for drugs to treat patients with COVID-19. Together with Chicago-based AbbVie and Japanese drugmaker Takeda Pharmaceutical, the Thousand Oaks biotech giant said Aug. 3 it had enrolled the first patients into a clinical trial for the anti-inflammatory drugs Otezla, cenicriviroc and Firazyr. Otezla is Read More →
Read More →
